Samuel Kintz serves as Executive at Enliven Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Samuel Kintz has executed 48 insider transactions totaling $4.9M, demonstrating a bearish approach to their equity position. Their most recent transaction on Nov 17, 2025 involved selling 12,500 shares valued at $272.8K.
Samuel Kintz currently holds 890,392 shares of Enliven Therapeutics, Inc. (ELVN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Samuel Kintz has been a net seller of ELVN stock. They have purchased $0 and sold $4.9M worth of shares.
Samuel Kintz's most recent insider trade was on Nov 17, 2025, when they sold 12,500 shares at $21.82 per share.
Get notified when new Form 4 filings are submitted
| $21.33 |
| Discretionary |
| Sep 26, 2025 | ELVN | $74.2K | Sale | 3,700 | $20.06 | Discretionary |
| Sep 23, 2025 | ELVN | $56.1K | Sale | 2,800 | $20.03 | Discretionary |
| Sep 19, 2025 | ELVN | $20.3K | Sale | 1,000 | $20.25 | Discretionary |
| Sep 17, 2025 | ELVN | $95.5K | Sale | 5,000 | $19.09 | Discretionary |
| Aug 20, 2025 | ELVN | $30.3K | Sale | 1,517 | $20.00 | Discretionary |
| Aug 19, 2025 | ELVN | $11.8K | Sale | 590 | $20.00 | Discretionary |
| Aug 18, 2025 | ELVN | $208.1K | Sale | 10,393 | $20.02 | Discretionary |
| Aug 26, 2024 | ELVN | $274.7K | Sale | 12,000 | $22.89 | Planned |
| Jul 31, 2024 | ELVN | $62.6K | Sale | 2,270 | $27.56 | Planned |
| Jul 25, 2024 | ELVN | $1.1K | Sale | 43 | $25.83 | Planned |
| Jul 25, 2024 | ELVN | $204.9K | Sale | 8,164 | $25.10 | Planned |
| Jul 25, 2024 | ELVN | $93.0K | Sale | 3,793 | $24.53 | Planned |
| Jun 25, 2024 | ELVN | $247.1K | Sale | 11,422 | $21.63 | Planned |
| Jun 25, 2024 | ELVN | $12.9K | Sale | 578 | $22.30 | Planned |
| May 28, 2024 | ELVN | $2.4K | Sale | 100 | $24.34 | Planned |
| May 28, 2024 | ELVN | $123.0K | Sale | 5,219 | $23.57 | Planned |
| May 28, 2024 | ELVN | $152.7K | Sale | 6,681 | $22.86 | Planned |
| May 28, 2024 | ELVN | $13.4K | Option Exercise | 12,000 | $1.12 | Planned |
| Apr 25, 2024 | ELVN | $13.4K | Option Exercise | 12,000 | $1.12 | Planned |
| Apr 25, 2024 | ELVN | $202.7K | Sale | 12,000 | $16.89 | Planned |
| Apr 11, 2024 | ELVN | $1.2M | Sale | 47,709 | $25.04 | Planned |
| Apr 11, 2024 | ELVN | $53.4K | Option Exercise | 47,709 | $1.12 | Planned |
| Mar 25, 2024 | ELVN | $13.4K | Option Exercise | 12,000 | $1.12 | Planned |
| Mar 25, 2024 | ELVN | $84.8K | Sale | 4,671 | $18.16 | Planned |
| Mar 25, 2024 | ELVN | $125.8K | Sale | 7,329 | $17.17 | Planned |
| Feb 26, 2024 | ELVN | $13.4K | Option Exercise | 12,000 | $1.12 | Planned |
| Feb 26, 2024 | ELVN | $127.2K | Sale | 7,624 | $16.69 | Planned |
| Feb 26, 2024 | ELVN | $75.4K | Sale | 4,376 | $17.24 | Planned |